Caution before embracing serum markers of liver fibrosis in clinical practice [2] (multiple letters)

Gastroenterology

Volumn 128, Issue 4, 2005, Pages 1145-1146

  Park, Gordon ^a   Katelaris, Peter ^a   Jones, D Brian ^a   Ngu, Meng ^a   Le Couteur, David ^b   Rosenberg, William ^c   Poynard, Thierry ^d   Ratziu, Vlad ^d   Benhamou, Yves ^d   Thabut, Dominique ^d   Moussalli, Joseph ^d  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYALURONIC ACID; LAMIVUDINE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ALGORITHM; BREATH ANALYSIS; CLINICAL PRACTICE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; HEMOLYSIS; HEPATITIS C; HISTOLOGY; HUMAN; LETTER; LIVER BIOPSY; LIVER FIBROSIS; MORBIDITY; NONALCOHOLIC FATTY LIVER; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

EID: 20244371189     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.02.044     Document Type: Letter

References (11)

1. W.M. Rosenberg M. Voelker R. Thiel M. Becka A. Burt D. Schuppan S. Hubscher Serum markers detect the presence of liver fibrosis a cohort study Gastroenterology 127 2004 1704 1713
2. J.C. Trinchet D.J. Hartmann D. Pateron M. Laarif P. Callard G. Ville M. Beaugrand Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests J Hepatol 12 1991 139 144
3. D.M. Bissell Assessing fibrosis without a liver biopsy are we there yet? Gastroenterology 127 2004 1847 1849
4. F. Oberti E. Valsesia C. Pilette M.C. Rousselet P. Bedossa C. Aube Y. Gallois Noninvasive diagnosis of hepatic fibrosis or cirrhosis Gastroenterology 113 1997 1609 1616
5. R.P. Myers M.H. Tainturier V. Ratziu A. Piton V. Thibault F. Imbert-Bismut D. Messous Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B J Hepatol 39 2003 222 230
6. G.J.-H. Park B.P. Lin M.C. Ngu D.B. Jones P.H. Katelaris Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol 15 2000 386 390
7. Park GJ-H, Jones DB, Katelaris PH. Value of AST/ALT ratio as fibrotic predictor in chronic hepatitis C. Am J Gastroenterol 2005 (in press).
8. S.G. Sheth S.L. Flamm F.D. Gordon S. Chopra AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection Am J Gastroenterol 93 1998 44 48
9. E. Giannini D. Risso F. Botta Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease Arch Intern Med 163 2003 218 224
10. 13C-caffeine breath test as a noninvasive, quantitative test of liver function Hepatology 38 2003 1227 1236
11. 13C-caffeine breath test distinguishes cirrhosis in chronic hepatitis B and is unaffected by short-term lamivudine therapy Gastroenterology 126 Suppl 2 2004 A710